Reshef, Yakir A.
Rumker, Laurie
Kang, Joyce B.
Nathan, Aparna
Korsunsky, Ilya
Asgari, Samira http://orcid.org/0000-0002-2347-8985
Murray, Megan B.
Moody, D. Branch
Raychaudhuri, Soumya http://orcid.org/0000-0002-1901-8265
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (5T32HG2295-17)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007753)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2ELP3_172101, P400PB_183823)
Foundation for the National Institutes of Health (T32HG010464, U19 AI111224, U01 HG009379, 1R01AR063759)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI049313, U19 AI111224)
Article History
Received: 18 April 2021
Accepted: 18 August 2021
First Online: 21 October 2021
Competing interests
: S.R. serves as a consultant for Gilead, Pfizer, Janssen and Rheos Medicines and is a founder of Mestag Therapeutics. I.K. serves as a consultant for Mestag Therapeutics. The other authors declare no competing interests.